MRI Imaging for Medical Device Preclinical Studies
HawkCell and NAMSA: A Seamless Partnership in Preclinical Research
MRI Images Captured and Reviewed Last Year
NAMSA Non-GLP Preclinical Projects in the Last 12 Months
Of HawkCell Team are Advanced Degree Scientists
NAMSA Labs with MRI Technology Available (2 US & 2 EU)
Cutting-Edge MRI Technology
Through our partnership with HawkCell based near Lyon, France, NAMSA is able to offer clients seamless access to the most sophisticated MRI technology for preclinical studies involving large animals. It offers high-resolution, non-invasive imaging capabilities that provide detailed anatomical and functional insights essential for the development and testing of medical devices. With HawkCell MRI, you can perform comprehensive assessments of cardiovascular, neurological, orthopedic, gastrointestinal, respiratory, renal, urological, vascular, hepatic, dermatological, and ophthalmic devices.
Learn more at www.hawkcell.com
Key features include:
- High-Resolution Imaging: Captures anatomical details and device interactions.
- Functional Imaging: Provides insights into physiological processes such as blood flow, tissue oxygenation, and diffusion.
- Quantitative Analysis: Delivers precise measurements of tissue volume, density, perfusion, and more.
- Advanced Post-Processing: Utilizes sophisticated algorithms for image segmentation, motion correction, and parametric mapping.
- Longitudinal Monitoring: Enables continuous, non-invasive observation of device performance and physiological changes over time.
Mobile MRI for On-Site Imaging
HawkCell also offers a mobile MRI unit, providing the flexibility and convenience of on-site imaging. This mobile unit is equipped with the same advanced MRI technology, ensuring high-quality imaging and analysis directly at your research facility. Key benefits of the mobile service unit include:
- On-Site Imaging: Eliminates the need to transport animals, reducing stress and logistical challenges.
- Immediate Results: Provides rapid imaging and analysis, accelerating the research process.
- Cost-Effective: Reduces costs associated with animal transport and external imaging services.
- Flexibility: Offers the ability to conduct studies in diverse locations, adapting to your research needs.
Meet NAMSA’s Preclinical Experts
Explore the depth of our team’s expertise.
-
Jack Risdahl, DVM, PhD
Principal Strategy Consultant, PreclinicalView Bio -
Gaëlle Clermont, PharmD, PhD
Principal Strategy ConsultantView Bio -
Michael A. Jorgenson, BS
Principal InterventionalistView Bio -
Tyler LaMont
Senior InterventionalistView Bio -
Corey Leet
Director, Regional Preclinical and In-Vivo Biocompatibility OperationsView Bio -
Jessica Barnhart
SurgeonView Bio
Related Services That May Interest You
Preclinical Research
Pathology Services